Other
Limeng Chen
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
Failure Rate
0.0%
0 terminated/withdrawn out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed trials have results
Key Signals
1 recruiting
Enrollment Performance
Analytics
N/A
1(100.0%)
1Total
N/A(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (3)
Showing 3 of 3 trials
NCT04714918Recruiting
Chinese CKD-MBD Prevalence Survey (CRISS-MBD)
Role: lead
NCT03598387Not ApplicableUnknown
Automated Peritoneal Dialysis Versus Intermittent Hemodialysis in Acute Kidney Injury
Role: lead
NCT04229485Unknown
Chinese Chronic Renal Insufficiency Study: Based on Smartphone Platform
Role: lead
All 3 trials loaded